Literature DB >> 23011461

Five-year changes in psychiatric treatment status and weight-related comorbidities following bariatric surgery in a veteran population.

Thomas Rutledge1, Abby L Braden, Gina Woods, Karen L Herbst, Lisa M Groesz, Michelle Savu.   

Abstract

BACKGROUND: Although bariatric surgery is an established treatment for obesity, less is known regarding the long-term effects of surgery on psychiatric function. This paper reports changes in psychiatric treatment status, weight, and weight-related comorbidities over 5 years of follow-up among a population of veterans completing bariatric surgery.
METHODS: We assessed 55 veterans undergoing bariatric surgery at a single Veteran Affairs medical center for 5 years post-surgery. Patients completed a pre-surgery clinical interview with a licensed psychologist. Using computerized medical records, we tracked pre- to post-surgery involvement with antidepressants, anxiolytics, psychotherapies, and overall psychiatric treatment visits along with changes in weight and metabolic function.
RESULTS: Rates of antidepressant use and/or involvement with psychotherapy for depression declined from 56.4 % at pre-surgery to 34.6 % at 5 years post-surgery, p = 0.01. Anxiolytic use and/or involvement with psychotherapy for anxiety, however, increased from 23.6 to 32.7 % pre- to 5 years post-surgery. Average psychiatric treatment volume remained similar to pre-surgery status across follow-up. These mixed indicators of psychiatric improvement occurred despite marked metabolic improvements from surgery. Mean percent excess weight loss = 51.7 and 41.3 (1 and 5 years post-surgery, respectively), systolic blood pressure (-6.8 mmHg (14.3)/-6.1 mmHg (12.8), respectively), glucose levels (-18.6 mg/dL (30.2)/-10.0 mg/dL (25.9), respectively), triglycerides (-78.2 mg/dL (96.7)/-69.1 mg/dL (102.2), respectively) and high-density lipoproteins (+7.1 (9.9)/+11.3 (11.3), respectively) levels each improved.
CONCLUSIONS: We report evidence of decreased antidepressant use and depression therapies following bariatric surgery, but no improvements on rates of anxiolytic use and anxiety therapies or on overall psychiatric treatment involvement. Despite metabolic improvements, bariatric patients with psychiatric histories may warrant ongoing attention to mental health.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011461     DOI: 10.1007/s11695-012-0722-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

1.  Bariatric surgery is associated with reduced depressive symptoms and better sexual function in obese female patients: a one-year follow-up study.

Authors:  Konstantinos Assimakopoulos; Katerina Karaivazoglou; Spiros Panayiotopoulos; Thomas Hyphantis; Gregoris Iconomou; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

2.  Congruence between clinical and research-based psychiatric assessment in bariatric surgical candidates.

Authors:  J E Mitchell; K J Steffen; M de Zwaan; T W Ertelt; J M Marino; A Mueller
Journal:  Surg Obes Relat Dis       Date:  2010-02-06       Impact factor: 4.734

3.  Veterans using and uninsured veterans not using Veterans Affairs (VA) health care.

Authors:  Karin M Nelson; Gordon A Starkebaum; Gayle E Reiber
Journal:  Public Health Rep       Date:  2007 Jan-Feb       Impact factor: 2.792

Review 4.  Impact of laparoscopic adjustable gastric banding on type 2 diabetes.

Authors:  J B Dixon; D K Murphy; J E Segel; E A Finkelstein
Journal:  Obes Rev       Date:  2011-08-31       Impact factor: 9.213

Review 5.  Psychological interventions for overweight or obesity.

Authors:  K Shaw; P O'Rourke; C Del Mar; J Kenardy
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

6.  Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study.

Authors:  J Karlsson; C Taft; A Rydén; L Sjöström; M Sullivan
Journal:  Int J Obes (Lond)       Date:  2007-03-13       Impact factor: 5.095

7.  Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study.

Authors:  John A Batsis; Abel Romero-Corral; Maria L Collazo-Clavell; Michael G Sarr; Virend K Somers; Francisco Lopez-Jimenez
Journal:  Mayo Clin Proc       Date:  2008-08       Impact factor: 7.616

Review 8.  Psychiatric disorders in bariatric surgery candidates: a review of the literature and results of a German prebariatric surgery sample.

Authors:  Barbara Mühlhans; Thomas Horbach; Martina de Zwaan
Journal:  Gen Hosp Psychiatry       Date:  2009-07-21       Impact factor: 3.238

Review 9.  Does obesity surgery improve psychosocial functioning? A systematic review.

Authors:  S Herpertz; R Kielmann; A M Wolf; M Langkafel; W Senf; J Hebebrand
Journal:  Int J Obes Relat Metab Disord       Date:  2003-11

Review 10.  Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set.

Authors:  Troy W Ertelt; James E Mitchell; Kathryn Lancaster; Ross D Crosby; Kristine J Steffen; Joanna M Marino
Journal:  Surg Obes Relat Dis       Date:  2008-04-16       Impact factor: 4.734

View more
  17 in total

1.  Prognostic Significance of Depressive Symptoms on Weight Loss and Psychosocial Outcomes Following Gastric Bypass Surgery: A Prospective 24-Month Follow-Up Study.

Authors:  Marney A White; Melissa A Kalarchian; Michele D Levine; Robin M Masheb; Marsha D Marcus; Carlos M Grilo
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

2.  The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults.

Authors:  Mahdieh Golzarand; Karamollah Toolabi; Roya Farid
Journal:  Surg Endosc       Date:  2017-04-04       Impact factor: 4.584

3.  Great Health Benefits But No Change in Employment or Psychopharmaceutical Drug Use 2 Years After Roux-en-Y Gastric Bypass.

Authors:  Susanna E Hanvold; Elin B Løken; Sofie F Paus; Eva Rustad de Brisis; Kirsti Bjerkan; Helga Refsum; Anne-Marie Aas
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

4.  The effects of roux en y gastric bypass surgery on neurobehavioral symptom domains associated with severe obesity.

Authors:  Dominique Musselman; Neeta Shenvi; Amita Manatunga; Andrew H Miller; Edward Lin; Nana Gletsu-Miller
Journal:  Physiol Behav       Date:  2019-02-11

5.  Clinical versus patient-reported measures of depression in bariatric surgery.

Authors:  Sudarshan Srivatsan; Vinay Guduguntla; Kelly Z Young; Aliasghar Arastu; Cameron R Strong; Ruth Cassidy; Amir A Ghaferi
Journal:  Surg Endosc       Date:  2018-02-12       Impact factor: 4.584

6.  Comparative Study of Resting Metabolic Rate and Plasma Amino Acid Profile in Patients Who Underwent Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy: 6-Month Follow-up Study.

Authors:  Mahdieh Golzarand; Karamollah Toolabi; Mehdi Hedayati; Kamal Azam; Masoomeh Douraghi; Kurosh Djafarian
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

7.  Dietary influences on cognition.

Authors:  A C Reichelt; L E Stoeckel; L P Reagan; C A Winstanley; K A Page
Journal:  Physiol Behav       Date:  2018-03-01

Review 8.  Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases.

Authors:  Jennifer M Erichsen; Jim R Fadel; Lawrence P Reagan
Journal:  Neuropharmacology       Date:  2021-11-08       Impact factor: 5.250

9.  Axis I disorders in adjustable gastric band patients: the relationship between psychopathology and weight loss.

Authors:  M J Hayden; K D Murphy; W A Brown; P E O'Brien
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

10.  Body Image and Emotional Eating as Predictors of Psychological Distress Following Bariatric Surgery.

Authors:  Shulamit Geller; Shiran Dahan; Sigal Levy; Gil Goldzweig; Sami Hamdan; Subhi Abu-Abeid
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.